Strategic Planning Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,074	Closed	-$1.28M	–	116
2024 Q1	$1.28M	Buy	3,074 +142	+5%	+$59.4K	0.32%	85
2023 Q4	$1.19M	Buy	+2,932	New	+$1.19M	0.4%	70